ALB and chronic myelogenous leukemia, BCR-ABL1 positive: These data suggest that ASR or other formulations of active astaxanthin have the potential to be used as a supplement to inhibit inflammation resulting from CML-HSA and may reduce autoinflammation induced by cell–cell interactions.